Enabling the public's
early access to good medicines

About Porton

Founded in 2005, Porton Pharma Solutions Ltd. is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for Small Molecules, TIDES, Biologics, ADCs from pre-clinical to commercial. As of September 30, 2023, we have a proven record for the delivery of more than 2700 projects and established cooperation with more than 800 global clients. With our 5000+ skilled employees working across 20+ sites around the globe, Porton is committed to becoming the most open, innovative and reliable pharmaceutical service platform in the world and enabling the public’s early access to good medicines. Porton is publicly listed on the Shenzhen Stock Exchange (Ticker: 300363).


Business Consulting

Please select what you want to consult

  • Requirement
  • Virtual Tour
  • On-Site Visit

Your information has been submitted successfully